Flash e-reader

 Go to e-reader chapter








Table 13.12

Adjusted Patient Survival, Heart-Lung Transplants

Survival at 3 Months, 1 Year, 5 Years, and 10 Years

  3 Months 1 Year 5 Years 10 Years
(Tx 2007 - 2008) (Tx 2007 - 2008) (Tx 2003 - 2008) (Tx 1998 - 2008)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 57 86.4% 4.5% 57 79.5% 5.4% 186 49.7% 4.1% 383 35.4% 3.1%
Transplant Center State Alabama 1 + + 1 + + 3 34.8% 20.4% 14 31.1% 12.3%
Arizona 1 0.0% 0.0% 1 0.0% 0.0% 5 22.1% 14.3% 15 47.1% 12.3%
California 24 91.8% 5.5% 24 87.7% 6.5% 49 48.2% 8.6% 87 26.3% 7.6%
Colorado 0 - - 0 - - 2 52.2% 24.6% 5 30.3% 17.9%
Florida 2 + + 2 + + 13 69.7% 12.2% 18 26.5% 15.1%
Illinois 0 - - 0 - - 4 52.2% 20.6% 7 56.3% 17.1%
Massachusetts 0 - - 0 - - 0 - - 1 0.0% 0.0%
Maryland 4 78.3% 18.0% 4 78.3% 18.0% 7 57.3% 17.2% 10 49.5% 14.6%
Michigan 0 - - 0 - - 0 - - 2 50.3% 25.0%
Minnesota 1 + + 1 + + 6 52.0% 17.9% 18 42.3% 11.5%
Missouri 1 + + 1 + + 5 58.1% 20.2% 17 25.5% 11.7%
North Carolina 1 + + 1 + + 9 35.6% 14.4% 25 31.5% 9.1%
New York 0 - - 0 - - 3 65.4% 22.4% 15 13.1% 8.4%
Ohio 5 + + 5 + + 18 51.3% 11.4% 20 44.7% 12.3%
Oregon 0 - - 0 - - 0 - - 1 0.0% 0.0%
Pennsylvania 13 75.4% 11.7% 13 58.7% 13.4% 42 41.6% 8.7% 82 36.8% 5.9%
Tennessee 0 - - 0 - - 3 67.6% 21.7% 9 22.7% 13.6%
Texas 2 42.0% 22.6% 2 42.0% 22.6% 12 65.7% 13.2% 21 53.4% 11.3%
Utah 0 - - 0 - - 0 - - 1 0.0% 0.0%
Washington 1 + + 1 + + 1 + + 3 + +
Wisconsin 1 100.0% 0.0% 1 0.0% 0.0% 4 72.8% 19.7% 12 49.4% 13.7%


Source: OPTN/SRTR Data as of October 1, 2010.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Patient survival follows patients from first transplant of this type until death.

Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on heart-lung transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.